Skip to main content
Log in

Perospirone

SM 9018

  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Murasaki M, Miura S. Long term-treatment of a new atypical neuroleptic, SM-9018 on patients with schizophrenia. Eur Neuropsychopharmacol 1996 Jun: 6 Suppl. 3: 201

    Article  Google Scholar 

  2. Murasaki M, Koyama T, Machiyama Y, et al. Clinical evaluation of a new antipsychotic, perospirone HCl, on schizophrenia: a comparative double-blind study with haloperidol [in Japanese]. Rinsho Hyoka 1997; 24 (2–3): 159–205

    Google Scholar 

  3. Kudo Y, Nakajima T, Saito M, et al. Clinical evaluation of a serotonin-2 and dopamine-2 receptor antagonist (SDA), perospirone HCl on schizophrenia: a comparative double-blind study with mosapramine HCl [in Japanese]. Rinsho Hyoka 1997; 24 (2–3): 207–48

    Google Scholar 

  4. Kato T, Hirose A, Ohno Y, et al. Binding profile of SM-9018, a novel antipsychotic candidate. Jpn J Pharmacol 1990 Dec; 54: 478–81

    Article  PubMed  CAS  Google Scholar 

  5. Ishida K, Ohno Y, Okada K, et al. Effects of SM-9018, a potential atypical antipsychotic, on electrically-evoked 3H-acetylcholine release in rat striatal slices. Jpn J Pharmacol 1993; 61 Suppl. I: 277P

    Google Scholar 

  6. Maruoka Y, Ohno Y, Kato T, et al. Effects of SM-9018, a potential atypical neuroleptic, on the central monoaminergic system in rats. Jpn J Pharmacol 1993 Aug; 62: 419–22

    Article  PubMed  CAS  Google Scholar 

  7. Hirose A, Kato T, Ohno Y, et al. Pharmacological actions of SM-9018, a new neuroleptic drugwith potent 5-hydroxytryptamine2 and dopamine2 antagonistic actions. Jpn J Pharmacol 1990 Jul; 53: 321–29

    Article  PubMed  CAS  Google Scholar 

  8. Shimizu H, Hirose A, Kato T, et al. Pharmacological profile of SM-9018, a novel neuroleptic candidate. Eur J Pharmacol 1990 Jul; 183: 1473–4

    Article  Google Scholar 

  9. Ohno Y, Kato T, Okada K, et al. Effect of SM-9018, a new atypical antipsychotic agent, on p-chloroamphetamineinduced hyperthermia in rats. Jpn J Pharmacol 1992; 58 Suppl. 1: 313

    Google Scholar 

  10. Saito A, Nishimura T, Fukushima M, et al. Pharmaco-EEG study of SM-9018, a D2 and 5-HT2 antagonist in healthy volunteers. Psychiatry Res — Neuroimaging 1997 Feb 7; 68: 173–4

    Article  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Perospirone. Drugs R&D 2, 60–62 (1999). https://doi.org/10.2165/00126839-199902010-00019

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-199902010-00019

Keywords

Navigation